JPS5359035A - Medical composition - Google Patents
Medical compositionInfo
- Publication number
- JPS5359035A JPS5359035A JP13316577A JP13316577A JPS5359035A JP S5359035 A JPS5359035 A JP S5359035A JP 13316577 A JP13316577 A JP 13316577A JP 13316577 A JP13316577 A JP 13316577A JP S5359035 A JPS5359035 A JP S5359035A
- Authority
- JP
- Japan
- Prior art keywords
- medical composition
- medical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU76150A LU76150A1 (en) | 1976-11-08 | 1976-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5359035A true JPS5359035A (en) | 1978-05-27 |
Family
ID=19728406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13316577A Pending JPS5359035A (en) | 1976-11-08 | 1977-11-08 | Medical composition |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5359035A (en) |
AU (1) | AU3041877A (en) |
BE (1) | BE860526A (en) |
DE (1) | DE2749318A1 (en) |
FR (1) | FR2369841A1 (en) |
IL (1) | IL53318A0 (en) |
LU (1) | LU76150A1 (en) |
NL (1) | NL7712100A (en) |
ZA (1) | ZA776645B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468391A (en) * | 1982-06-25 | 1984-08-28 | Ayerst, Mckenna & Harrison, Inc. | Combination of β-adrenoceptor antagonists and anxiolytic agents |
JPS6124516A (en) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | Long active tablet |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1919342A1 (en) * | 1969-04-16 | 1970-12-03 | Boehringer Sohn Ingelheim | Cardiac active combination preparations |
-
1976
- 1976-11-08 LU LU76150A patent/LU76150A1/xx unknown
-
1977
- 1977-11-02 NL NL7712100A patent/NL7712100A/en not_active Application Discontinuation
- 1977-11-04 DE DE19772749318 patent/DE2749318A1/en active Pending
- 1977-11-04 FR FR7733216A patent/FR2369841A1/en not_active Withdrawn
- 1977-11-07 BE BE182381A patent/BE860526A/en unknown
- 1977-11-07 ZA ZA00776645A patent/ZA776645B/en unknown
- 1977-11-07 IL IL53318A patent/IL53318A0/en unknown
- 1977-11-07 AU AU30418/77A patent/AU3041877A/en active Pending
- 1977-11-08 JP JP13316577A patent/JPS5359035A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL53318A0 (en) | 1978-01-31 |
FR2369841A1 (en) | 1978-06-02 |
LU76150A1 (en) | 1978-07-10 |
DE2749318A1 (en) | 1978-05-11 |
ZA776645B (en) | 1978-08-30 |
AU3041877A (en) | 1979-05-17 |
NL7712100A (en) | 1978-05-10 |
BE860526A (en) | 1978-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS52134026A (en) | Medical composition | |
JPS5359016A (en) | Pharmatoceutical composition | |
JPS52151712A (en) | Composition for medical preparation | |
JPS5316787A (en) | Specificcreactive composition | |
AU2732277A (en) | Soil-hardening composition | |
JPS5289700A (en) | Medical composition having antiiulcer activity | |
JPS5355360A (en) | Heattactivating composition | |
JPS542341A (en) | Medical composition | |
AU3152677A (en) | Pharmaceutical composition | |
JPS52117437A (en) | Antiicoccidium composition | |
JPS5215826A (en) | Medical composition | |
JPS5334930A (en) | Medical composition | |
JPS5428829A (en) | Antiithrombosis medical composition | |
JPS5315428A (en) | Medical composition | |
JPS5341436A (en) | Antiiparasite composition | |
IL51365A0 (en) | Coccidiocidal composition | |
JPS52142752A (en) | Moistureeresistant composition | |
IE44735L (en) | Fibrinogenase composition | |
JPS5470432A (en) | Medical composition | |
JPS52139731A (en) | Medical composition | |
JPS5359035A (en) | Medical composition | |
JPS5381610A (en) | Antiicancer medical composition | |
JPS542335A (en) | Medical composition | |
JPS52103201A (en) | Photoosensitive composition | |
JPS52136922A (en) | Antiiallergy medical composition |